Trial intelligence / Profile preview

Efficacy and Safety of Impoyz (DFD-06) Cream in Moderate to Severe Plaque Psoriasis

NCT02445807Phase 3Completed

Sponsor
Promius Pharma
Start
Dec 2015
Primary completion
Jul 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of clobetasol in plaque psoriasis, sponsored by Promius Pharma. Started Dec 2015; status: completed.

02

Drugs

clobetasol
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on NCT02445807.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02445807.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call